Pharmaceuticals in South Africa

November 2025 | 46 pages | ID: PB5F41FBE88EN
MarketLine

Abstracts

Summary

Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
• The South African pharmaceuticals market recorded revenues of $6.8 billion in 2024, representing a compound annual growth rate (CAGR) of 5.4% between 2019 and 2024.
• The anti-infective drugs segment accounted for the market's largest proportion in 2024, with total revenues of $0.7 billion, equivalent to 10.7% of the market's overall value.
• The South African pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.8%.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in South Africa
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Africa
• Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the South Africa pharmaceuticals market with five year forecasts

Reasons to Buy

• What was the size of the South Africa pharmaceuticals market by value in 2024?
• What will be the size of the South Africa pharmaceuticals market in 2029?
• What factors are affecting the strength of competition in the South Africa pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitors in South Africa's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What are the strategies of the leading players?
7.3. What are the most recent market developments?

8 COMPANY PROFILES

8.1. Pfizer Inc
8.2. Aspen Pharmacare Holdings Ltd
8.3. Adcock Ingram Holdings Ltd
8.4. Bayer AG

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: South Africa pharmaceuticals market value: $ million, 2019-24
Table 2: South Africa pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: South Africa pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: South Africa pharmaceuticals market geography segmentation: $ million, 2024
Table 5: South Africa pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Pfizer Inc: Key Facts
Table 7: Pfizer Inc: Annual Financial Ratios
Table 8: Pfizer Inc: Key Employees
Table 9: Pfizer Inc: Key Employees Continued
Table 10: Aspen Pharmacare Holdings Ltd: Key Facts
Table 11: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 12: Aspen Pharmacare Holdings Ltd: Key Employees
Table 13: Adcock Ingram Holdings Ltd: Key Facts
Table 14: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 15: Adcock Ingram Holdings Ltd: Key Employees
Table 16: Bayer AG: Key Facts
Table 17: Bayer AG: Annual Financial Ratios
Table 18: Bayer AG: Key Employees
Table 19: Bayer AG: Key Employees Continued
Table 20: Bayer AG: Key Employees Continued
Table 21: South Africa Size of Population (Million), 2020-23
Table 22: South Africa Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 23: South Africa GDP (Current Prices, $ Billion), 2020-24
Table 24: South Africa Inflation, 2020-23
Table 25: South Africa Consumer Price Index (Absolute), 2020-24
Table 26: South Africa Exchange Rate, 2019-24

List Of Figures

LIST OF FIGURES

Figure 1: South Africa pharmaceuticals market value: $ million, 2019-24
Figure 2: South Africa pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: South Africa pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: South Africa pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in South Africa, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Africa, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Africa, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2024